Your browser doesn't support javascript.
loading
Cardiac sympathetic nerve activity trends after renal denervation in heart failure with preserved ejection fraction.
Shiraki, Tatsuya; Mizuno, Hiroya; Kishi, Takuya; Asakura, Masanori; Asanoi, Hidetsugu; Yasumura, Yoshio; Sakata, Yasushi.
Afiliación
  • Shiraki T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Mizuno H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Kishi T; Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare, Fukuoka, Japan.
  • Asakura M; Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Asanoi H; Toyama Nishi General Hospital, Toyama, Japan.
  • Yasumura Y; Division of Cardiology, Amagasaki Chuo Hospital, Amagasaki, Japan.
  • Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
ESC Heart Fail ; 11(4): 2426-2431, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38659233
ABSTRACT
This case report describes the application of ultrasound renal denervation (uRDN) using the Paradise System in a patient with heart failure with preserved ejection fraction. Initially, the cardiac sympathetic nerve activity of the patient exhibited a late heart/mediastinum (H/M) ratio of 2.00 and a washout rate of 66.0% by cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy. Subsequently, the patient underwent transfemoral uRDN targeting the left, right upper, and right lower renal arteries. At the 6 month follow-up, no significant change was observed in 123I-MIBG findings; however, the estimated stressed blood volume (eSBV) decreased from 1722 to 1029 mL/70 kg. At 18 months, 123I-MIBG findings improved, with the late H/M ratio reaching 2.76 and the washout rate decreasing to 43.1%. This case report highlights the potential of uRDN in reducing eSBV within 6 months and subsequently improving cardiac sympathetic nerve activity at the 18 month follow-up.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Volumen Sistólico / Simpatectomía / Sistema Nervioso Simpático / Insuficiencia Cardíaca / Riñón Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: ESC Heart Fail Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Volumen Sistólico / Simpatectomía / Sistema Nervioso Simpático / Insuficiencia Cardíaca / Riñón Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: ESC Heart Fail Año: 2024 Tipo del documento: Article País de afiliación: Japón